Tag: Research
-
Mechanism Behind Common Parkinson’s Mutation Discovered
Northwestern Medicine scientists uncovered the molecular process behind a buildup of toxic proteins in Parkinson’s patients, a discovery that may lead to improved therapies.
-
Symposium Spotlights Sex Inclusion in Autoimmunity Research
The 2nd Annual Symposium on Sex Inclusion in Biomedical Research, held on the anniversary of the National Institutes of Health’s landmark sex-inclusion policy, highlighted research on sex bias in autoimmune diseases.
-
Testosterone-linked Molecule Explains Gender Differences in MS
Northwestern Medicine scientists have identified a guardian molecule triggered by testosterone that appears to protect males from multiple sclerosis.
-
Genetic Basis Uncovered for Glaucoma
Northwestern Medicine scientists have discovered mutations that cause improper drainage and a buildup of ocular pressure leading to glaucoma, suggesting a path towards future treatments.
-
PhD Student Explores Role of Exosomes in Cancer Metastasis
Northwestern Medicine scientists have demonstrated that tiny vesicles called exosomes released from non-metastatic melanoma cells trigger an immune response that prevents cancer from spreading throughout the body.
-
Scientists Identify Direct Contact Between Mitochondria and Lysosomes
For the first time, Northwestern Medicine scientists have discovered that two key cellular structures, mitochondria and lysosomes, are in direct contact with each other.
-
Nanoshells Provide New Approach to Targeted Chemotherapy Delivery
A team of scientists has demonstrated a novel approach to delivering cancer drugs directly to tumor cells, through gold nanoparticles that can be remotely triggered to release therapies.
-
Interventions in the Real World
Across the medical school, investigators are leading grants for community-engaged research projects that tackle a wide range of specific health challenges in Chicagoland and beyond.
-
Drug Regimen Boosts Outcomes for Some Breast Cancer Patients
A combination of three therapies was found to provide the greatest benefit to patients with metastatic breast cancer classified as HER2- and hormone receptor-positive, who aren’t candidates for chemotherapy, according to a Northwestern Medicine clinical trial.
-
Emergency Department Program for Older Adults Cuts Hospitalizations by 33 Percent
An emergency department program focused on geriatric transitional care has reduced the risk of unnecessary admission of older patients at Northwestern Medicine by 33 percent.
